bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Update

bioMérieux S.A. (OTCMKTS:BMXMF) saw a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 225,800 shares, a decrease of 15.5% from the August 15th total of 267,100 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 2,258.0 days.

Wall Street Analysts Forecast Growth

Separately, UBS Group raised bioMérieux to a “strong-buy” rating in a report on Thursday, August 22nd.

bioMérieux Stock Performance

BMXMF opened at $122.50 on Wednesday. The company’s 50 day moving average is $109.42 and its 200 day moving average is $105.93. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.03 and a quick ratio of 1.19. bioMérieux has a 12-month low of $90.23 and a 12-month high of $122.52.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.